4//SEC Filing
Deeg Mark Albert 4
Accession 0001209191-18-031890
CIK 0001505512other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:39 PM ET
Size
5.4 KB
Accession
0001209191-18-031890
Insider Transaction Report
Form 4
Deeg Mark Albert
Chief Medical Officer
Transactions
- Award
Common Stock (Right to Buy)
2018-05-17+100,000→ 100,000 totalExercise: $0.71Exp: 2028-05-16→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001708820
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:39 PM ET
- Size
- 5.4 KB